SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2001 MW MEDICAL, INC. --------------------------- (Exact name of registrant as specified in its charter) NEVADA 001-14297 86-0907471 - ------------ ------------- --------------- (State or other (Commission File Number) (IRS Employer jurisdiction of Identification Number) incorporation) 6617 N. Scottsdale Road, Suite 103 Scottsdale, Arizona 85250 - ---------------------------------- ---------- (Address of principal executive offices) (Zip Code) Registrants telephone number, including area code (480) 315-8600 -------------- None - ------------------------------- ---------- (Former name or former address, (Zip Code) if changed since last report.) ITEM 1. CHANGES IN CONTROL OF REGISTRANT None ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS None ITEM 3. BANKRUPTCY OR RECEIVERSHIP None ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT (1) Grant Thornton, LLP, MW's principal independent accountants, were dismissed as of January 17, 2001. (2) Grant Thornton's independent auditor's report for December 31, 1999 was unqualified. They did not provide a report for any earlier period. (3) The decision to change accountants was approved by the board of directors. (4) There were no disagreements with Grant Thornton on any matter of accounting principles or practices, financial statement disclosure, or auditing scope of procedure which, if not resolved to the satisfaction of Grant Thornton would have caused it to make reference to the subject matter of the disagreement in connection with its report during MW's most recent fiscal years and any subsequent interim period preceding this dismissal. (5)	As part of the audit for the year ended December 31, 1999, Grant Thornton notified us of internal control weakness related to proper documentation of sales records and documentation and control over inventory movement. (6) The Company has engaged a new accountant, Smith and Company, as of January 19, 2001. Smith and Company were the Company's auditors for fiscal year end 1998 and earlier years. ITEM 5. OTHER EVENTS None ITEM 6. RESIGNATIONS OF REGISTRANT'S DIRECTORS None ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS Financial Statements: None Exhibits: Letter from Grant Thornton, LLP to Securities and Exchange Commission dated January 24, 2001 ITEM 8. CHANGE IN FISCAL YEAR None SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MW MEDICAL, INC. /s/ Dean Drummond - -------------------------------------- Dean Drummond, Chief Financial Officer Date: January 24, 2001 ----------------